Ralph Wong
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 16
- Cancer Treatment and Pharmacology 5
-
- Gastric Cancer Management and Outcomes 7
-
- Genetic factors in colorectal cancer 4
- Cancer Research top 5%
-
- Economic and Financial Impacts of Cancer 6
- Health Systems, Economic Evaluations, Quality of Life 4
-
- Neuroendocrine Tumor Research Advances 4
- Co-authors
- Sheryl KoskiEduardo Díaz‐RubioWerner ScheithauerArié FigerLeonard B. SaltzStephen ClarkeJim CassidyTsai‐Shen Yang
- Journals
- Journal of Clinical Oncology (9 papers)British Journal of Cancer (3 papers)Investigational New Drugs (2 papers)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Ralph Wong
35 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Hepatology 953
- Oncology 2.8k
- Pulmonary and Respiratory Medicine 1.2k
- Pathology and Forensic Medicine 487
- Cancer Research 398
Countries citing papers authored by Ralph Wong
This map shows the geographic impact of Ralph Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Wong more than expected).
Fields of papers citing papers by Ralph Wong
This network shows the impact of papers produced by Ralph Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Wong. The network helps show where Ralph Wong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ralph Wong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 16 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 4 | |
| 4 | 2019 | 5 | |
| 5 | 2018 | 13 | |
| 6 | 2018 | 1 | |
| 7 | 2015 | 253 | |
| 8 | 2013 | 38 | |
| 9 | 2012 | 97 | |
| 10 | 2011 | 48 | |
| 11 | 2011 | 22 | |
| 12 | 2011 | 178 | |
| 13 | 2011 | 18 | |
| 14 | 2010 | 33 | |
| 15 | 2010 | 7 | |
| 16 | 2009 | 35 | |
| 17 | Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Studybreakdown → | 2008 | 2275 |
| 18 | 2007 | 14 | |
| 19 | 2006 | 36 | |
| 20 | 1995 | 5 |
About Ralph Wong
Ralph Wong is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 3.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (16 papers), Gastric Cancer Management and Outcomes (7 papers), Economic and Financial Impacts of Cancer (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer Treatment and Pharmacology (5 papers), Neuroendocrine Tumor Research Advances (4 papers), Genetic factors in colorectal cancer (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). The work is most often cited by research in Hepatology (953 citations), Oncology (2.8k citations) and Pulmonary and Respiratory Medicine (1.2k citations). Ralph Wong has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Sheryl Koski, Eduardo Díaz‐Rubio, Werner Scheithauer, Arié Figer, Leonard B. Saltz, Stephen Clarke, Jim Cassidy, Tsai‐Shen Yang, Fernando Rivera and Félix Couture. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Investigational New Drugs, Current Oncology and Endocrine Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.